亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

異喹啉物,33456-68-7

 
 
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
品牌 異喹啉物
型號 33456-68-7
規格 異喹啉物
過期 長期有效
更新 2012-02-14 17:12
 

湖北省康寶泰精細化工有限公司

企業會員第14年
資料未認證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2012-02-14
  • 鮮經理 (女士)   銷售經理
詳細說明

異喹啉物

產品名稱:異喹啉物
英文名:4-[2-(3,4-Dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)- isoquinolinyl)ethyl]benzenesulfonamide
分子式:C20H22N2O5S
分子量:402
熔點:203~206℃
CAS號:33456-68-7
含量:≥98.5%
外觀:白色或類白色結晶性粉末
用途:格列喹酮中間體。也用作腦梗死的預防劑和/或治療劑,尤其是急性階段的腦梗死的預防劑和/或治療劑。此外,它還用作預防劑和/或治療劑,用于改善與腦梗死、尤其是急性階段的腦梗死相關的神經癥狀。


湖北康寶泰廠家供應:阿曲庫銨,阿曲庫銨草酸鹽,苯磺酸甲酯,2',3'-二-O-乙?;?5'-脫氧-5-氟胞苷,2-脫氧-D-核糖,氟達拉賓,N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-氨基嘧啶,順苯磺酸阿曲庫銨,順曲庫銨縮合物草酸鹽,4-哌啶基哌啶,5-氮雜胞嘧啶,1,2,3-三乙酰氧基-5-脫氧-D-核糖,1,5戊二醇二丙烯酸酯等醫藥中間體及醫藥原料,歡迎來電垂詢!

舉報收藏 0評論 0
更多>本企業其它產品
鹽酸甲氯芬酯,鹽酸氯酯醒,3685-84-5 4-(2-氨乙基)苯磺酰胺,35303-76-5 154330-68-4,普盧利沙星中間體,PL-7 113046-72-3,普盧利沙星中間體,PL-9 112984-60-8,普盧利沙星中間體,PL-11 溴甲基聯苯并四氮唑,TTBB,124750-51-2 3-甲氧基-2-環己烯-1-酮,16807-60-6
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |